Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination
Clinical trial NCT00160316 · COMPLETED
Trial details
- NCT number
- NCT00160316
- Sponsor
- Solvay Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2007-12-01
- Enrollment
- 454
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.